Liletta

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instanceOf intrauterine device
gptkbp:activeDuring levonorgestrel
gptkbp:approves contraception
gptkbp:assemblyLocation performed in a healthcare setting
gptkbp:availability prescription only
gptkbp:brand gptkb:Liletta
gptkbp:classification yes
gptkbp:clinicalTrials ACOG recommendations
used for long-term contraception
Liletta_clinical_trial_results
gptkbp:contraindication nausea
pregnancy
headaches
breast tenderness
mood changes
active pelvic infection
uterine abnormalities
gptkbp:decommissioningDate after 3 years or as needed
can be removed by a healthcare provider
gptkbp:duration up to 3 years
gptkbp:effectiveDate over 99% effective
gptkbp:hasCapacity available through manufacturer
gptkbp:hasPopulation women of reproductive age
gptkbp:healthcare informed consent required
high satisfaction rates reported
most users are in their 20s and 30s
must be inserted by trained provider
https://www.w3.org/2000/01/rdf-schema#label Liletta
gptkbp:impact may lighten periods
may stop periods altogether
gptkbp:manufacturer Allergan
gptkbp:marketedAs gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_States
gptkbp:notable_event required before insertion
gptkbp:offers varies by insurance
gptkbp:patentType yes
gptkbp:regulatoryCompliance approved_by_FDA
gptkbp:relatedPatent gptkb:Mirena
gptkb:Kyleena
Skyla
gptkbp:releaseDate 2015
gptkbp:researchInterest ongoing studies on long-term effects
gptkbp:route intrauterine
gptkbp:runnerUp annual gynecological exams
recommended after insertion
gptkbp:safetyFeatures generally considered safe
gptkbp:services pre-insertion counseling recommended
gptkbp:setIn during menstrual period
gptkbp:sideEffect expulsion
perforation
cramping
irregular bleeding
gptkbp:triggerType prevents ovulation
thickens cervical mucus
inhibits sperm motility
gptkbp:userReviews generally positive